Home · Portfolio
Portfolio
100+ companies. 29 FDA-approved products.
For 32 years, Pappas Capital has created, funded, and guided life-science companies across the US, Canada, and Asia — spanning therapeutics, medical devices and diagnostics, and agriculture. Every logo links to the company. To see the approved products mapped to the patients they reach, explore the Portfolio Company Impact map.
4D Molecular Therapeutics (4DMT)
Achillion Pharmaceuticals
Aclara Biosciences
Aer Therapeutics
Afferent Pharmaceuticals
Aktis Oncology
Allievex Corporation
Amplyx Pharmaceuticals
Anthera Pharmaceuticals
Arena Pharmaceuticals
ArgoMed
Athersys
Balance Therapeutics
BaroSense
Bayhill Therapeutics
BioAtla
BioSyntech
BrainCells Inc.
Calyx Therapeutics
CardioDx
CeNeRx BioPharma
Cequent Pharmaceuticals
Cerexa
Chimerix
Cognetix
CoLucid Pharmaceuticals
CuraSen Therapeutics
Curis (formerly Reprogenesis)
Curzion Pharmaceuticals
Cyclerion Therapeutics
Dynogen Pharmaceuticals
EBM Solutions
Elitra Pharmaceuticals
Emerald BioAgriculture
Enlaza Therapeutics
Envisia Therapeutics
FlowCardia
Gentis
IlluminOss Medical
Istari Oncology
Kezar Life Sciences
LEAD Therapeutics
LipoScience
Liquidia Corporation
Lumena Pharmaceuticals
Marina Biotech (now Adhera Therapeutics)
Milestone Pharmaceuticals
Mirati Therapeutics (formerly MethylGene)
Mirum Pharmaceuticals
Nereus Pharmaceuticals
NuVasive
Optherion
Orphomed
Panacos Pharmaceuticals
Peninsula Pharmaceuticals
Plexigen
Plexxikon
Reneo Pharmaceuticals
Ribometrix
Rotation Medical
Selventa
Sensys Medical
Signase
Solu Therapeutics
Sorriso Pharmaceuticals
Spherics
Syndax Pharmaceuticals
Syntonix Pharmaceuticals
TargeGen
TESARO
Thrasos Therapeutics
Tune Therapeutics
TyRx
Ultragenyx Pharmaceutical
Variagenics
Veralox Therapeutics
X-Ceptor Therapeutics
Company names and logos are shown to identify Pappas Capital’s real portfolio companies. Several early-stage companies were advanced under, or acquired by, the organizations linked here.